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Highlights 
 Retention time (RT) and collision cross section (CCS) prediction of small-molecule drugs 
 Single and combined artificial neural network prediction models of RT and CCS 
 Prediction errors evaluated with external validation set 
 91.9% within both 2 minutes RT error and 5% relative CCS (combined ANN model) 
 
Abstract 
Exact mass, retention time (RT), and collision cross section (CCS) are used as identification parameters 
in liquid chromatography coupled to ion mobility high resolution accurate mass spectrometry (LC-IM-
HRMS). Targeted screening analyses are now more flexible and can be expanded for suspect and non-
targeted screening. These allow for tentative identification of new compounds, and in-silico predicted 
reference values are used for improving confidence and filtering false-positive identifications. In this 
work, predictions of both RT and CCS values are performed with machine learning using artificial 
neural networks (ANNs). Prediction was based on molecular descriptors, 827 RTs, and 357 CCS values 
from pharmaceuticals, drugs of abuse, and their metabolites. ANN models for the prediction of RT or 
CCS separately were examined, and the potential to predict both from a single model was investigated 
for the first time. The optimized combined RT-CCS model was a four-layered multi-layer perceptron 
ANN, and the 95th prediction error percentiles were within 2 minutes RT error and 5% relative CCS 
error for the external validation set (n=36) and the full RT-CCS dataset (n=357). 88.6% (n=733) of 
predicted RTs were within 2 minutes error for the full dataset. Overall, when using 2 minutes RT error 
and 5% relative CCS error, 91.9% (n=328) of compounds were retained, while 99.4 % (n=355) were 
retained when using at least one of these thresholds. This combined prediction approach can therefore 
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be useful for rapid suspect/non-targeted screening involving HRMS, and will support current 
workflows. 
Keywords: collision cross section prediction; retention time prediction; artificial neural networks  
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1. Introduction 
Liquid chromatography coupled to high resolution accurate mass spectrometry (LC-HRMS) has 
enabled comprehensive toxicological screening of large numbers of trace contaminants in complex 
matrices such as biological samples and environmental matrices [1–6]. The addition of ion mobility 
spectrometry (IMS) has recently represented a significant increase in capability and allows for 
separation of ions in the gas-phase based on their mobility differences in an applied electric field [7,8]. 
Ions are then measured by their drift times through a tube containing a buffer gas. While drift times are 
system dependent, the average collision cross sections (CCS) between the ion and buffer gas can be 
derived when using constant operating procedures. The CCS of an ion is correlated to its size, shape, 
and charge. After calibration, the drift times observed from a travelling-wave IMS (TW-IMS) system 
can be used to determine CCS values [9]. CCS from TW-IMS have been shown to be matrix and 
system independent [10,11], and the use of LC-IMS-HRMS have been used to reduce the number of 
false-positive identifications and can replace other screening metrics for confirmatory analysis as a 
result (e.g. isotopic pattern match and fragment ions) [12]. The use of RT and CCS for confirmatory 
analyses means there also exists a lesser need for data-dependent fragmentation as the full-scan HRMS 
fragmentation can be filtered both on RT and drift time alignment [7]. This can then be applied to 
targeted, suspect, and non-targeted screening as required using the same dataset. 
A common challenge, particularly in forensic screening, is keeping methods updated with relevant 
compounds. More than two new psychoactive substances enter the American and European drug 
market every week, on average [13,14]. Also, with the increase of long-distance travel for vacations 
and work, local populations can be exposed to pollutants and drugs not prescribed in their home 
countries. Suspect and non-targeted screening approaches have been utilized for identification of 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
5 
 
compounds before acquisition of reference standards [4,15–17]. For this purpose, in-silico 
fragmentation matching [18,19] and prediction of retention time (RT) have been shown to reduce the 
list of potential compounds [1,20]. In-silico prediction of CCS and IMS drift times have utilized 
molecular modelling techniques [21–23]; however, models based on molecular descriptors have shown 
similar results while drastically reducing computing time [24–27], which corresponds to findings for 
prediction of the reduced ion mobility constants [28,29].  
The aim of this work was to predict both RT and CCS with the use of artificial neural networks 
(ANNs), a machine learning technique that has been demonstrated for predicting analytical reference 
values, and has only very recently been utilized for prediction of either RT [1,30] or CCS [24] for use 
in screening. However, combination of these tools to understand their added value for preliminary 
suspect identifications has not yet been performed. A previously developed ANN model for RT 
prediction was trained and validated herein on a new, significantly larger dataset gathered under 
different LC conditions and in a different laboratory; ANN and linear regression models for prediction 
of CCS were trained and validated, and finally a combined model for prediction of both RT and CCS 
simultaneously was critically evaluated. This novel approach to in silico prediction of both RT and 
CCS alongside the use of HRMS data will markedly increase the speed and confidence in tentative 
identifications of potentially large numbers of new compounds. 
2. Materials and methods 
2.1. Chemicals 
Reference standards of pharmaceuticals, drugs of abuse, and their metabolites were purchased from 
Lipomed GmbH (Bad Säckingen, Germany), Cerilliant (Round Rock, TX, USA), Toronto Research 
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Chemicals (Toronto, Canada), and SelleckChem (Houston, TX, USA). All reference standards were of 
≥98% purity. Methanol, water, acetonitrile, propanol, and formic acid (LC-MS grade) were obtained 
from Fisher Scientific (Loughborough, UK). Leucine enkephalin was purchased from Sigma-Aldrich 
(Copenhagen, Denmark). 
2.2. Instrumentation 
Analyses were performed on two separate systems, an ultra-high performance liquid chromatography-
time-of-flight mass spectrometer (UHPLC-TOF; System 1) and a UHPLC-TW-IMS-TOF (System 2). 
RT were obtained on System 1 with an ACQUITY UPLC I-Class coupled with a Xevo G2-S QTOF 
(Waters MS Technologies, Manchester, United Kingdom), and CCS values were obtained on System 2: 
an ACQUITY UPLC H-Class coupled with a VION IMS QTOF (Waters MS Technologies, 
Manchester, United Kingdom). LC separations on both systems were achieved using an Acquity UPLC 
HSS C18 column (150 mm × 2.1 mm, 1.8 μm), which was maintained at a constant temperature of 50 
°C and a flow rate of 0.4 mL/min. Mobile Phase A consisted of 5 mM aqueous ammonium formate 
buffer adjusted to pH 3 with formic acid, and Mobile Phase B consisted of acetonitrile with 0.1% v/v 
formic acid. The gradient was 0 min to 0.5 min: 13% (B); from 0.5 min to 10 min: 13% to 50% (B); 
from 10 min to 10.75 min: 50% to 95% (B); from 10.75 min to 12.25 min: 95% (B); and from 12.25 
min to 12.5 min: 95% to 13% (B); from 12.5 min to 15 min: 13% (B). The total run time was 15 min, 
and the injection volume was 3 μL. Ion mobility (System 2) was calibrated with a Major Mix IMS/Tof 
Calibration Kit from Waters, drift times were measured, and CCS values were calculated by the UNIFI 
software (Waters MS Technologies, Manchester, United Kingdom). Nitrogen (N2) was used as drift gas 
in the TW-IMS of System 2.  
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With respect to mass spectrometry, both systems were used in positive electrospray ionization (Z-
spray) mode with the following settings: nebulization gas 1000 L/h (System 1) and 800 L/h (System 2), 
with a desolvation temperature of 400 °C; cone gas flow 10 L/h (System 1) and 20 L/h (System 2); 
source temperature 150 °C; capillary voltage 800 V; cone voltage 25V; and argon as the collision gas. 
The low collision energy was set at 4 eV, and the high collision energy was ramped from 10 to 40 eV. 
The acquisition time was the entire run, with a scan time of 0.200 s. The minimum mass-to-charge 
(m/z) was 50 and the maximum was 950 (System 1) or 1000 (System 2). Mass calibration of System 1 
was performed with 5 mM sodium formate solution in propanol: water (90:10, v/v), while System 2 
was mass calibrated with the Major Mix IMS/Tof Calibration Kit from Waters. Lock mass was used 
with leucine enkephalin as a reference mass at m/z 556.2766 on both systems. 
2.3. Reference values 
In total, RTs for 869 compounds were determined from reference standards (Dataset I). Of these, the 
CCS of the proton adduct was determined for 364 compounds (Dataset II). For both datasets, 
compounds identified as multiple LC peaks were excluded. RTs were recorded on both systems, 
however, only RTs from System 1 was used for prediction. The differences in dataset sizes were 
primarily due to reference standards only being analyzed on System 1. Other factors were no observed 
protonation adducts, either due to high affinity for metal adducts or heavy in-source fragmentation. 
2.4. Molecular descriptor generation 
A total of 869 unique simplified molecular-input line-entry system (SMILES) strings were generated 
with ChemScript v16.0 from PerkinElmer (Waltham, MA, USA) from an in-house database of mol-
files. Each SMILES string corresponded to a single compound and was used to generate a total of 105 
molecular descriptors with Parameter Client freeware [31,32]. The selected descriptors were 
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constitutional descriptors, functional group counts, and molecular properties. Additional descriptors 
were generated for each compound: thirteen descriptors from ACD/Percepta (ACD/Labs, Toronto, 
Canada) and six descriptors from ChemScript v16.0 from PerkinElmer (Waltham, MA, USA). The full 
list of SMILES and corresponding descriptor values are available in Table A.1. Compounds for which 
the descriptor generation failed were excluded from the ANN modelling. 
2.5. Descriptor selection and ANN optimization 
ANN modelling was performed using Trajan Neural Networks v6.0. Prior to any evaluation, Dataset I 
& II were split into optimization and external validation sets with compounds chosen at random, in 
proportions 80:20 and 90:10, respectively. RT values for compounds exclusive to Dataset I were added 
as an external validation set in Models RT2 & RT-CCS (only regarding the RT prediction). The 
external validation set were used to reduce the risk of overfitting to the optimization set. 
In total, four ANNs were trained and optimized. Single-output models for RT or CCS included Models 
RT1 & RT2, which were used with Dataset I & II, respectively, to predict RT, and Model CCS, which 
used Dataset II for predicting CCS. Model RT-CCS was a two-output model for predicting both CCS 
and RT simultaneously and used on Dataset II. The ANN was trained with backpropagation and 
conjugated gradient descent. Models RT1 & RT2 were based on 16 descriptors described by Barron 
and McEneff [33]. For Models CCS & RT-CCS, the number of descriptors was first reduced with 
feature selection and further reduced during the ANN optimization. Feature selection was performed  
by first removing duplicated descriptors and those with near-zero variance within the dataset. Near-zero 
variance was defined as having no variance or a higher than 95:5 ratio between most common and 
second-most-common descriptor values. Subsequently, for both models, feature selection with the 
Trajan software was repeated n=6 times each with forwards, backwards, and genetic selection. Only 
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descriptors selected in at least 16 of the 18 times in each case were retained as a priority given their 
linear correlation to CCS and/or RT. For the remaining descriptors, feature selection was repeated n=4 
times with each method; only retaining those selected all twelve times. For the ANN optimization, the 
corresponding optimization set was split into the subsets: training, verification, and test set in a ratio of 
70:15:15. The “Intelligent Problem Solver” of the Trajan software was used in four rounds per model. 
The ANN was trained with backpropagation and conjugated gradient descent. The outputs of the input 
nodes were scaled linear, and the hyperbolic activation function was used in the hidden nodes. In each 
round, choices were made based on prediction errors of the verification and test sets of the best 
network(s) from the previous round. The first round was used to select network type between radial 
basis functions, three/four-layer multi-layer perceptrons (MLPs), probabilistic neural networks, or 
generalized regression neural networks; with continuous resampling of training, verification, and 
(internal) test sets, and sub-selection of descriptors for Models CCS & RT-CCS. In the second round, 
only the optimal network type was used, where in the third round, network type, test set, and 
descriptors were fixed. In the fourth and final round, all but the network architecture (number of nodes 
in hidden layer) were locked. The final best network was then applied to the respective external 
validation set of the model. Further descriptor analysis was carried out with the built-in sensitivity 
analysis feature, which rates descriptors based on the deterioration in modeling performance when the 
descriptor is made unavailable. 
2.6 Modelling CCS data by linear regression 
Ordinary least squared regression of CCS as a function of molecular weight (MW) was performed for 
Dataset II (Model CCS-MW). The optimization set of Dataset II was split into training and test sets 
(70:30), and was resampled 250 times, each time making a model using linear regression of CCS as a 
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function of MW based on the training set. The model with the lowest 90th percentile prediction error 
for the full optimization set was selected and tested regarding the external validation set. 
3. Results and Discussion 
Thirty-one compounds were removed due to peak splitting of the early-eluting compounds (<1.1 min), 
and an additional eleven compounds were removed due to failed descriptor generation, 42 in total for 
Dataset I and seven for Dataset II. RT and CCS values, SMILES, and molecular descriptors are 
available in Table A.1 for included compounds. The molecular descriptors evaluated in this work were 
limited to the groups: constitutional descriptors, functional group counts, and molecular properties, 
comprising 124 molecular descriptors. However, the presented RT prediction of Models RT1 & RT2 
was based upon previous work that had sampled a larger number of molecular descriptors [1,30,33]. 
3.1. Retention time modelling 
All RT values were an average of at least four measurements obtained from mixtures of reference 
standards in solvents. RTs were not determined in spiked matrix samples since little to no influence of 
matrix on RTs (±0.02 min) have been observed with whole blood on System 1 [4]. In Table 1, key 
values of the prediction errors of all three RT models are given, and Figure 1 shows measured RT 
versus predicted RT. Predicted RT values for each compound is available in Table A.2. The optimized 
networks for Models RT1, RT2, & RT-CCS were four-layered MLPs. Like the previously reported 
contributions of molecular descriptors [33] to predictions of RT, logD, and atomic logP (AlogP; Ghose-
Crippen octanol-water partition coefficient) were the most influential for all three models, with the 
number of carbons and number of oxygens being the third most influential for Models RT1 & RT2, 
respectively. The descriptors used in Model RT-CCS for prediction of RT were also used for CCS 
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prediction. MW and logD were the most influential, while number of unsubstituted benzene carbon and 
compound logP (ClogP) were the third and fourth most influential. Sensitivity analysis results and full 
list of descriptors are available in Table A.3. 
Model RT1 showed improved prediction accuracy compared to Models RT2 & RT-CCS regarding the 
full external validation. This difference is most likely due to a larger optimization set and the difference 
in compounds available for optimization. Dataset I contained a larger variety of pharmaceutical 
compounds than Dataset II, and these were, therefore, not available in the optimization of Models RT2 
& RT-CCS. This is shown by the difference in the prediction errors between the external validation sets 
when Dataset I was/was not included. This difference can be illustrated with principal component 
analysis based on the descriptors as shown in figure 2. The principal component analysis shows that 
models limited to Dataset II in the optimization have smaller applicability domain than those optimized 
on Dataset I. Model RT-CCS showed a small improvement over Model RT2, which can be explained 
by the descriptors being selected specifically for this dataset and, therefore, this analytical system. In 
general, this shows the need to retrain ANN prediction models when the experimental values are 
system dependent and the limitation that only compounds similar to the compounds of the optimization 
can be expected to fall within prediction error tolerances. 
3.2. Collisional Cross-section modelling 
The CCS of the protonated adduct was for all compounds in the range 128-250 Å2. All CCS values 
were an average of at least four measurements obtained from mixtures of reference standards in 
solvents. Predicted CCS values are available in Table A.4. A summary of the performance of models 
for CCS prediction is presented in Table 2. The linear regression using MW provided a good 
prediction; however, the ANN models improved upon this, and a less than 5% relative prediction error 
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for 95% of the external validation set was achieved with Models CCS & RT-CCS. Model CCS used 
eight molecular descriptors: MW, parachor, number of bonds, number of hydrogens, and the Wiener 
index. All these describe the size of the molecule. The last three descriptors were Ghose-Viswanadhan-
Wendoloski drug-like indices: Psychotic-80, Inflammat-50 and Infective-80 [34]. Figure 3 shows the 
measured versus the predicted CCS. In total, 66.4% (n=237) and 61.1% (n=218) were within 2% 
relative error for Models CCS & RT-CCS, respectively. Model CCS performed better than RT-CCS on 
the optimization set (which was comprised of the same compounds), while prediction accuracy was 
similar for the external validation set. This difference is likely due to compromises in the optimization 
of Model RT-CCS, since the selection of descriptors and networks was based on prediction of both 
output variables. However, sensitivity analysis of Model RT-CCS showed that it relied mainly on a 
smaller number of descriptors for predictions such as, MW, LogD, nCbH, and ClogP. Generation of 
models using a smaller set of such descriptors failed to yield better or even similar prediction accuracy 
and this was not considered further. Generation of the larger descriptor dataset did not add significantly 
to the time required for predictions, as several thousand descriptors could be calculated simultaneously 
in a matter of minutes. ANN predictions using an optimized model took seconds. Depending on the 
ANN software, the combined RT-CCS model is advantageous when both values are desired, since 
maintaining a single ANN and predicting new values is simplified. 
Other studies have predicted RT [1] and CCS [24] with ANNs, albeit separately, and found they could 
add confidence to identifications in suspect and non-targeted screening. However, our CCS prediction 
errors are slightly lower than those of Bijlsma et al. [24], most likely due to their smaller number of 
CCS cases used for optimization (205 vs 321), and their larger CCS value range (132-307 Å2 vs 128-
250 Å2). That said, it was via the combination of both tools that the most significant advancement in in 
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silico capability was observed. Overall, the simultaneous RT-CCS model developed here achieved 
prediction accuracy within 2 minutes for 88.6% (n=733) of predicted RT values, and 95.2% (n=340) of 
predicted CCS values were within 5% relative error. Impressively, the true-positive rate was 91.9% 
(n=328) and 99.4% (n=355), when the criteria for both or either of predicted values were within their 
error limits, respectively. These limits retain a reasonable number of the true-positive identifications 
and represent a significant improvement in in silico predictive capability for screening which has not 
been demonstrated previously to our knowledge. However, the correlation between MW and CCS 
indicates a lack of accuracy amongst isomers and isobars, which is relevant since the predictions are 
intended as orthogonal identification criterions to accurate mass measurements. The predicted CCS 
were not orthogonal to accurate mass measurements in this study, as illustrated by the isomers, 
dosulepin and pizotifen. These isomers had a 4.7% relative CCS difference, which was the largest 
difference of CCS values between isomers in Dataset II. Tentative identification based on the predicted 
CCS values was possible when ranking was based on the prediction error; however, in both cases, they 
were within a 3% relative CCS error limit. When grouping Dataset II by exact mass with a tolerance of 
3 mDa, 26 groups contain 2-4 compounds, in total, 60 compounds. The true-positive rate for these 
compounds were 96.7% (n=58) when applying both filters. However, the false-positive rate was 84.1% 
(n=74), and in 23.3% (n=14) of identifications a potential false-positive identification was removed. In 
two of these 14 cases, the false-positive identification was avoided based on predicted CCS. While this 
number shows room for improvement, it should be remembered these numbers are mostly based on 
filtering of structurally related isomers. When these limits are applied to large suspect and non-targeted 
databases, the true-positive rate will stay the same; while the false-positive rate will likely decrease. 
Similarly, when suspect and non-targeted screening are applied to authentic samples, the predicted 
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error filters can filter matrix components, which without filtering would be false-positive 
identifications. 
Conclusion 
Prediction models for RT, CCS, and a combination thereof have been presented. ANN prediction can 
support tentative identifications in suspect and non-target screening; however, limited selectivity 
between isomers and isobars were observed. The presented models include a large range of small-
molecule compounds of toxicological interest, and prediction accuracies were reliant on the number 
and diversity of compounds used in optimization and testing. Overall, the use of simple molecular 
descriptors, which can be generated for new compounds in a matter of minutes, allowed for fast 
prediction of RT and CCS, enabling application in large compound databases like those used in suspect 
and non-targeted screening.  
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Appendices  
Appendix A: Single Excel file (.xlsx) with four sheets with text referenced tables. 
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Figure Captions 
Figure 1: Scatterplot of measured and predicted retention times for Models RT1, RT2, & RT-CCS, in 
the first, second and third row, respectively. The left column shows the optimization sets; training, 
verification, and test set. The right column shows the external validation, where points with less than 1 
min error are black, absolute error between 1 min and 2 min are gray, and more than or equal to 2 min 
error are white. 
Figure 2: Principal component analysis of the 124 descriptors, showing the difference in applicability 
domain. 
Figure 3: Scatterplot of measured and predicted collision cross section for Models CCS-MW, CCS, & 
RT-CCS, in the first, second and third row, respectively. The left column shows the optimization set; 
training, verification, and test set. The right column shows the external validation, where points with 
less than 2% absolute relative error are black, less than 5% absolute relative error are grey, and more 
than or equal to 5% absolute relative error are white. 
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Table 1: Retention time prediction accuracy summary. Train, verification, and test sets are subsets 
of the optimization set. 
Model 
Best 
Network 
Architectur
e 
Set N R2 
Slope 
(SE) 
Intercep
t (SE) 
Mean 
absol
ute 
error 
(min) 
Median 
absolut
e error 
(min) 
95th 
percenti
le (min) 
RT1 MLP 16-14-
5-1 
Optimizati
on 661 0.87 
0.88 
(0.01) 
0.80 
(0.10) 0.88 0.64 2.46 
  Train 463 0.85 0.86 
(0.02) 
0.91 
(0.12) 
0.91 0.69 2.45 
  Verificatio
n 
99 0.92 0.89 
(0.03) 
0.57 
(0.19) 
0.71 0.50 1.86 
  Test 99 0.87 0.91 
(0.04) 
0.60 
(0.26) 
0.88 0.53 2.91 
  Validation 166 0.87 0.87 
(0.03) 
0.98 
(0.18) 
0.97 0.79 2.40 
RT2 MLP 16-12-
3-1 
Optimizati
on 
321 0.87 0.88 
(0.02) 
0.70 
(0.12) 
0.80 0.57 2.14 
  Train 225 0.86 0.86 
(0.02) 
0.82 
(0.15) 
0.81 0.59 2.18 
  Verificatio
n 
48 0.91 0.89 
(0.04) 
0.57 
(0.29) 
0.69 0.56 1.66 
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  Test 48 0.88 0.91 
(0.05) 
0.23 
(0.33) 
0.84 0.54 2.12 
  Validation 36 0.85 0.85 
(0.06) 
0.37 
(0.41) 
1.03 0.85 2.21 
  Validation
* 
506 0.81 0.86 
(0.02) 
1.03 
(0.14) 
1.13 0.82 3.09 
RT-
CCS 
MLP 24-9-
7-2 
Optimizati
on 
321 0.90 0.90 
(0.02) 
0.57 
(0.11) 
0.73 0.60 1.89 
  Train 225 0.89 0.89 
(0.02) 
0.65 
(0.13) 
0.74 0.59 1.98 
  Verificatio
n 
48 0.95 0.92 
(0.03) 
0.29 
(0.24) 
0.65 0.57 1.40 
  Test 48 0.87 0.93 
(0.05) 
0.37 
(0.35) 
0.77 0.66 1.89 
  Validation 36 0.87 0.86 
(0.06) 
0.59 
(0.38) 
0.88 0.75 1.93 
  Validation
* 
506 0.82 0.86 
(0.02) 
0.73 
(0.14) 
1.14 0.92 2.85 
*Additional compounds from dataset I included. MLP: multilayer perceptron; SE: standard error 
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Table 2: Collision Cross Section prediction accuracy overview. Train, verification, and test sets are subsets of the 
optimization set. 
Model 
Best Network 
Architecture 
Set N R2 Slope (SE) Intercept (SE) 
Mean 
absolute 
error (%) 
Median 
absolute 
error (%) 
95th 
percentile 
(%) 
CCS-MW n/a Optimization 321 0.91 0.94 (0.02) 9.89 (2.95) 2.6 1.9 7.5 
  Train 225 0.91 0.91 (0.02) 15.77 (3.37) 2.7 2.0 8.0 
  Test 96 0.91 1.04 (0.03) -7.01 (5.77) 2.2 1.6 4.8 
  Validation 36 0.94 0.93 (0.04) 12.41 (7.32) 2.5 1.9 5.8 
CCS MLP 8-11-7-1 Optimization 321 0.97 0.97 (0.01) 4.56 (1.81) 1.7 1.3 4.2 
  Train 225 0.96 0.96 (0.01) 7.38 (2.22) 1.7 1.2 4.5 
  Verification 48 0.98 1.01 (0.02) -0.86 (3.95) 1.5 1.3 3.4 
  Test 48 0.97 1.01 (0.03) -1.28 (4.82) 1.8 1.9 3.4 
  Validation 36 0.96 0.93 (0.03) 12.31 (5.40) 1.8 1.7 4.0 
RT-CCS MLP 24-9-7-2 Optimization 321 0.96 0.96 (0.01) 7.59 (2.00) 1.9 1.5 5.0 
  Train 225 0.96 0.95 (0.01) 7.90 (2.36) 1.9 1.5 5.1 
AC
CE
PT
ED
 M
AN
US
CR
IPT
  
26 
 
  Verification 48 0.97 0.95 (0.03) 9.21 (4.57) 1.7 1.3 4.1 
  Test 48 0.94 0.98 (0.04) 4.69 (6.26) 2.2 1.8 4.8 
  Validation 36 0.96 0.93 (0.03) 11.01 (5.89) 1.9 1.3 4.4 
MLP: multilayer perceptron; SE: standard error 
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